Health Day - ONLINE EDITION

FDA To Step Up Oversight of Indian Drug Makers

More inspectors planned as India emerges as growing source of pharmaceuticals

  • Print

FRIDAY, Feb. 21, 2014 (HealthDay News) -- The head of the U.S. Food and Drug Administration said Friday that her agency would increase monitoring of drugs from pharmaceutical companies in India.

As the second largest supplier of over-the-counter and prescription drugs sold in the United States, India "stands out as particularly important," FDA Commissioner Dr. Margaret Hamburg said during an afternoon news conference.

Commenting on her recent trip to India, Hamburg said she signed a non-binding "statement of intent" with Indian government officials that will lead to more cooperation between the FDA and its Indian counterpart.

As the amount of drugs made in India has increased, problems with quality have increased and the FDA has sent warning letters to several Indian drug makers in recent years, according to published reports.

"If products are sold in the United States for use by American citizens, then those products do have to meet our standards," Hamburg said.

During the press briefing, Hamburg was asked repeatedly if the FDA was singling out India.

"The fact that we have increased our presence in India is true, but it reflects the fact that India is a very significant and growing player in the U.S. marketplace," she said.

Currently, there are 12 FDA inspectors in India, and that number is expected to grow, Hamburg said.

She added that the FDA's efforts in India aren't any different from those in the United States or other countries.

"If a company is manufacturing a product for sale within the United States, they have to meet our regulatory standards and requirements," she said. "What's happening in India is consistent with what happens within the United States and throughout the world."

In 2012, India's Ranbaxy Laboratories had to recall dozens of batches of its generic version of the cholesterol-lowering drug Lipitor after the discovery of glass particles among the ingredients used in production. And last May the company's U.S. subsidiary agreed to pay $500 million in fines and penalties for selling adulterated drugs and lying to federal regulators, the Associated Press reported.

More information

For more on FDA drug regulations, visit the U.S. Food and Drug Administration.

Fact Check

Fact Check

Have you found an error, or know of something we’ve missed in one of our stories?
Please use the form below and let us know.

* Required
  • Please post the headline of the story or the title of the video with the error.

  • Please post exactly what was wrong with the story.

  • Please indicate your source for the correct information.

  • Yes

    No

  • This will only be used to contact you if we have a question about your submission, it will not be used to identify you or be published.

  • Cancel

Having problems with the form?

Contact Us Directly
  • Print

You can comment on most stories on winnipegfreepress.com. You can also agree or disagree with other comments. All you need to do is be a Winnipeg Free Press print or e-edition subscriber to join the conversation and give your feedback.

You can comment on most stories on winnipegfreepress.com. You can also agree or disagree with other comments. All you need to do is be a Winnipeg Free Press print or e-edition subscriber to join the conversation and give your feedback.

Have Your Say

New to commenting? Check out our Frequently Asked Questions.

Have Your Say

Comments are open to Winnipeg Free Press print or e-edition subscribers only. why?

Have Your Say

Comments are open to Winnipeg Free Press Subscribers only. why?

The Winnipeg Free Press does not necessarily endorse any of the views posted. By submitting your comment, you agree to our Terms and Conditions. These terms were revised effective April 16, 2010.

letters

Make text: Larger | Smaller

LATEST VIDEO

Blake Wheeler talks about past season

View more like this

Photo Store Gallery

  • JOE BRYKSA/WINNIPEG FREE PRESS Local-(Standup photo)- A wood duck swims through the water with fall refections in Kildonan Park Thursday afternoon.
  • KEN GIGLIOTTI  WINNIPEG FREE PRESS / July 23 2009 - 090723 - Bart Kives story - Harry Lazarenko Annual River Bank Tour - receding water from summer rains and erosion  damage by flood  and ice  during spring flooding -  Red River , Lyndale Dr. damage to tree roots , river bank damage  , high water marks after 2009 Flood - POY

View More Gallery Photos

Poll

Do you think Manitoba needs stronger regulations for temporary workers?

View Results

View Related Story

Ads by Google